Etanercept, Adalimumab, Infliximab, Ustekinumab, Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab Tildrakizumab are among the biologic drugs used for the treatment of Psoriasis. Objectives: (i) To assess the relative drug survival of Etanercept, Adalimumab, Infliximab, Ustekinumab, Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab Tildrakizumab in patients with psoriasis. (ii) To investigate factors associated with drug withdrawal. (iii) To investigate drug survival of Etanercept, Adalimumab, Infliximab, Ustekinumab, Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab Tildrakizumab. (iv) To compare drug survival of Etanercept, Adalimumab, Infliximab, Ustekinumab, Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab Tildrakizumab to previously used regimens

Drug survival dei farmaci biologici per la psoriasi moderato-severa: analisi dei fattori associati alla sospensione del farmaco in 425 pazienti ​

NONNATO, PIETRO
2021/2022

Abstract

Etanercept, Adalimumab, Infliximab, Ustekinumab, Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab Tildrakizumab are among the biologic drugs used for the treatment of Psoriasis. Objectives: (i) To assess the relative drug survival of Etanercept, Adalimumab, Infliximab, Ustekinumab, Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab Tildrakizumab in patients with psoriasis. (ii) To investigate factors associated with drug withdrawal. (iii) To investigate drug survival of Etanercept, Adalimumab, Infliximab, Ustekinumab, Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab Tildrakizumab. (iv) To compare drug survival of Etanercept, Adalimumab, Infliximab, Ustekinumab, Secukinumab, Ixekizumab, Brodalumab, Guselkumab, Risankizumab Tildrakizumab to previously used regimens
2021
Drug survival of biological drugs for moderate-to-severe psoriasis: analysis of factors associated with drug withdrawal in 425 patients ​
Psoriasi
Drug survival
Biologici
File in questo prodotto:
File Dimensione Formato  
Tesi di Laurea Pietro Nonnato 1148096.pdf

accesso riservato

Dimensione 815.76 kB
Formato Adobe PDF
815.76 kB Adobe PDF

The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.12608/30558